Protection conferred by a fully recombinant sub-unit vaccine against Yersinia pestis in male and female mice of four inbred strains
- PMID: 10930691
- DOI: 10.1016/s0264-410x(00)00108-0
Protection conferred by a fully recombinant sub-unit vaccine against Yersinia pestis in male and female mice of four inbred strains
Abstract
In this paper, we describe for the first time the use of a fully recombinant sub-unit vaccine for plague. We have compared the protection afforded by the recombinant vaccine against Yersinia pestis in male and female mice of four inbred strains. We also determined the in vivo cellular memory and antibody response after one year. The recombinant vaccine was capable of inducing protective immunity, against subcutaneous and aerosol challenge, in mice from all four strains. Although, there was some breakthrough in the CBA males challenged with 10(7) median lethal dose (MLDs) the other mice regardless of sex or strain were well protected even at this extreme challenge dose. In both male and female mice, the specific IgG titres to both antigens peaked at day 28 and 35 and in female mice these titres were maintained for >1 year.
Similar articles
-
Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates.Microb Pathog. 2007 Jan;42(1):11-21. doi: 10.1016/j.micpath.2006.09.003. Epub 2006 Nov 14. Microb Pathog. 2007. PMID: 17107769
-
Humoral and cellular immune correlates of protection against bubonic plague by a live Yersinia pseudotuberculosis vaccine.Vaccine. 2019 Jan 3;37(1):123-129. doi: 10.1016/j.vaccine.2018.11.022. Epub 2018 Nov 19. Vaccine. 2019. PMID: 30467064
-
A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague.Vaccine. 1997 Jul;15(10):1079-84. doi: 10.1016/s0264-410x(96)00303-9. Vaccine. 1997. PMID: 9269050
-
Protection against lethal subcutaneous challenge of virulent Y. pestis strain 141 using an F1-V subunit vaccine.Sci China C Life Sci. 2007 Oct;50(5):600-4. doi: 10.1007/s11427-007-0071-8. Sci China C Life Sci. 2007. PMID: 17879056
-
A single dose sub-unit vaccine protects against pneumonic plague.Vaccine. 2000 Oct 15;19(4-5):566-71. doi: 10.1016/s0264-410x(00)00159-6. Vaccine. 2000. PMID: 11027822
Cited by
-
Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV.Infect Immun. 2006 Aug;74(8):4910-4. doi: 10.1128/IAI.01860-05. Infect Immun. 2006. PMID: 16861680 Free PMC article.
-
Plague Prevention and Therapy: Perspectives on Current and Future Strategies.Biomedicines. 2021 Oct 9;9(10):1421. doi: 10.3390/biomedicines9101421. Biomedicines. 2021. PMID: 34680537 Free PMC article. Review.
-
Current challenges in the development of vaccines for pneumonic plague.Expert Rev Vaccines. 2008 Mar;7(2):209-21. doi: 10.1586/14760584.7.2.209. Expert Rev Vaccines. 2008. PMID: 18324890 Free PMC article. Review.
-
TNFα and IFNγ contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague.Vaccine. 2010 Dec 16;29(2):357-62. doi: 10.1016/j.vaccine.2010.08.099. Epub 2010 Sep 15. Vaccine. 2010. PMID: 20840834 Free PMC article.
-
Principles of antidote pharmacology: an update on prophylaxis, post-exposure treatment recommendations and research initiatives for biological agents.Br J Pharmacol. 2010 Oct;161(4):721-48. doi: 10.1111/j.1476-5381.2010.00939.x. Br J Pharmacol. 2010. PMID: 20860656 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources